Get started
Author

Sarah Lawless

Observed names: S. Lawless, S.E. Lawless
OpenAlex ID: A5111922507
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
2020 · Andreas Agathangelidis, Anastasia Chatzidimitriou, et al. · Blood · 133
PDF
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia
2019 · Fary Diop, Riccardo Moia, et al. · Haematologica · 90
Glofitamab and Epcoritamab in the Real World: A UK Multicentre Retrospective Analysis of Efficacy, Tolerability and Practical Implications
2024 · Euan Haynes, Kushani Ediriwickrema, et al. · Blood · 7
PDF
TP53 Mutations Identified Using NGS Comprise the Overwhelming Majority of TP53 Disruptions in CLL: Results From a Multicentre Study
2022 · Mark A. Catherwood, Dorte Wren, et al. · Frontiers in Oncology · 6
326 | Glofitamab and Epcoritamab for Large B Cell Lymphoma in 319 Real World Patients: a Retrospective Uk Analysis of Efficacy, Tolerability and Practical Implications
2025 · E. Haynes, W. Townsend, et al. · Hematological Oncology · 1
PDF
Multiparametric integration improves diagnostic categorisation of mature, non-CLL B-cell leukemias including atypical CLL - results from the prospective enable-NGS study
2025 · Li Yuan Chan, Matthew Cross, et al. · Blood
PDF
Next-generation sequencing of TP53 mutations negates the need for FISH assessment in the investigation of TP53 aberrations
2020 · Mark Catherwood, Doriane Cavalieri, et al. · Leukemia & lymphoma/Leukemia and lymphoma
Coexistence of inversion 16 in chronic myeloid leukaemia in blast crisis
2016 · Mark A. Catherwood, Peter McGrattan, et al. · Journal of Hematopathology
PDF
Does primary chemotherapy in locally advanced non-small cell lung cancer allow down-staging and facilitate further treatment?
2008 · S.E. Lawless, S. Matthews, et al. · Lung Cancer
Works count: 9
Citation count: 237
H-index: 4
I10-index: 2
Year
Topic
Type